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Available online 19 February 2011Experimental autoimmune encephalomyelitis (EAE) is a condition induced in some susceptible
species to the study of multiple sclerosis (MS). The platelet activating factor (PAF) is an
important mediator of immune responses and seems to be involved in MS. However, the
participation of PAF in EAE and MS remains controversial. Thus, in this study, we aimed to
evaluate the role of PAF receptor in the pathogenesis of EAE. EAE was induced using an
emulsion containing MOG35–55. EAE-induced PAF receptor knock out (PAFR−/−) mice presented
milder disease when compared to C57BL/6 wild type (WT) animals. PAFR−/− animals had lower
inflammatory infiltrates in central nervous system (CNS) tissue when compared to WT mice.
However, intravital microscopy in cerebral microvasculature revealed similar levels of rolling
andadhering leukocytes in bothWTandPAFR−/−mice. Interleukine (IL)-17 andchemokinesC–C
motif legends (CCL)2 and CCL5were significantly lower in PAFR−/−micewhen compared toWT
mice. Brain infiltrating cluster of differentiation (CD)4+ leukocytes and IL-17+ leukocytes was
diminished inPAFR−/−whencompared toWTmice.Taken together,our results suggest that PAF
receptor is important in the induction and development of EAE, although it has no influence in
rolling and adhesion steps of cell recruitment. The absence of PAF receptor results in milder
disease by altering the type of inflammatorymediators and cells that are present in CNS tissue.
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Multiple sclerosis is considered a classical T-cell-mediated
autoimmune disease of the central nervous system (CNS),
though its underlying causes remain obscure (McFarland and
Martin, 2007). Most of the current knowledge on the mecha-
nisms of CNS inflammation has been gathered from experi-
mental autoimmune encephalomyelitis (EAE) which is
considered an animal model of multiple sclerosis (Gold et al.,
2006). Indeed, several researchers regard EAE as an important
tool to exploremechanismsof autoimmunityand inflammation
in CNS, ultimately contributing to provide insights for
therapeutic strategies (Steinman and Zamvil, 2005; Ransohoff,
2006).
Manymediators are involved in CNS inflammation, such as
chemokines, cytokines, Toll-like receptors. Among these, only
a few works have investigated the role of platelet activating
factor (PAF) in EAE. PAF is a potent and versatile mediator of
inflammation that is produced by numerous cell types,
especially by leukocytes (Stafforini et al., 2003; Ishii and
Shimizu, 2000). PAF acts on a single receptor (PAFR) that may
be expressed on the cellular membrane or the outer leaflet of
the nucleus of various cell types, mainly leukocytes, platelets
and endothelial cells (Ishii and Shimizu, 2000; Marrache et al.,
2002).
Howat et al. (1989) were the first to propose a role for PAF in
EAE. Blockade of PAF receptor with CV6209 led to decline in
EAE severity (El Behi et al., 2007). In addition, enzymes
involved in the production of PAF are upregulated in the CNS
after EAE induction (Kihara et al., 2008). On the other hand,
PCA4248 and WEB2170 antagonists of PAF were not able to
suppress the clinical signs of EAE (Vela, 1991). Even though
previous studies in EAE are not in complete agreement, PAF
seems to act as a proinflammatory molecule. More recently, it
was proposed that PAF plays a dual role in the course of EAE. In
the induction phase, PAF would be involved in processes of
blood–brain barrier breakdown and induction of the synthesis
of inflammatory mediators. In the chronic phase, PAF would
be contributing to prevent remission due to loss of phagocytic
activity of microglia with the release of cytotoxic mediators
such as tumor necrosis factor (TNF)-α (Kihara et al., 2005).
Thus, in this work, we aimed to investigate the role of PAF in
the course of EAE using animals lacking the PAF receptor. We
performed intravital microscopy, analysis of cytokines and
chemokines in CNS and investigated cellular markers in brain
tissue.Fig. 1 – Clinical score (A) and weight (B) of groups WT (n=7)
and PAFR−/− (n=7) EAE-induced mice with MOG35–55.
(A) PAFR−/− mice (●) present decreased clinical score when
compared to WT mice (▲). (B) Weight of WT mice decreases
significantly when compared to controls (Δ) and to PAFR−/−
mice. PAFR−/− mice not induced with EAE were omitted in
(B) for better visualization. Data are presented asmean of EAE
score and error bars represent ±SEM.2. Results
2.1. Absence of PAF receptor attenuates EAE
WT animals developed EAE with onset of clinical signs after
11 days of immunization andapeak ofmotor impairment after
14 days of immunization. All WT mice developed signs of
weakness and paralysis of both tail and hind limbs and there
was a significant weight loss. In contrast, PAFR−/− animals
developed a milder disease, with significant lower clinical
score (p<0.01) and delayed onset when compared to WT mice(Fig. 1A). PAFR−/− animals alsohada lowerweight loss (p<0.001)
when compared toWTmice (Fig. 1B) and 2 out of 7mice did not
develop any clinical signs.
2.2. EAE-induced PAFR −/− animals present distinct
cellular infiltrates in CNS
We performed hematoxylin and eosin histopathology to
evaluate changes in CNS tissue after EAE induction. EAE was
induced in WT and PAFR−/− mice and animals were sacrificed
after 14 days of EAE induction (peak of clinical signs). Spinal
cord from mice was removed and fixed in 10% buffered
formalin. The histopathological aspect of spinal cord of WT
and PAFR−/− animals is shown in Fig. 2. InWT animals (n=4) an
inflammatory infiltrate composed predominantly of mono-
nuclear cells (Fig. 2A and C) was observed. In PAFR−/− animals
(n=4), there was a reduced area of inflammation (Fig. 2D)
which presented mainly eosinophils and neutrophils (Fig. 2E
and F). The infiltrated area was predominantly submeningeal
and distributed along vessels that penetrate the spinal cord
tissue. There was associated edema and vascular congestion
of meninges in both WT and PAFR−/− mice.
Fig. 2 –Histopathological aspectsof spinal cordofWT (A,CandE) andPAFR−/− (B,DandF).Miceweresacrificedatday14p.i. Panoramic
view of longitudinal sections of spinal cord showing submeningeal increase of cellularity indicating inflammatory cell infiltration
(arrows) inWT (A) andPAFR−/− (B) animals. InCandDnotice theperivascular infiltrationof cells (arrows), edemaandassociated tissue
damage. In E and F the aspect of mononuclear and polimorphonuclear inflammatory cells, mostly eosinophils (arrows).
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measureN-acetyl-β-D-glucosaminidase (NAG) activity, an index
ofmacrophagesequestration. EAE-inducedWTanimalspresent
increased NAG activity (OD=3.27±0.26) when compared to
controls (2.58±0.07; p<0.05) and EAE-induced PAFR−/− animals
(OD=2.26±0.13; p<0.001) (Fig. 3). There was no difference
between EAE-induced PAFR−/− and control PAFR−/− mice.
2.3. Milder disease in PAFR−/− is independent of rolling and
adhesion of leukocytes in CNS microvasculature
To investigate whether PAFR−/− mice presented altered rolling
and adhesion of leukocytes in CNS microvasculature, we
performed intravital microscopy in the cerebral microvascula-ture on day 14 post immunization. EAE-induced WT mice
presented elevated levels (p<0.001) of rolling (Fig. 4A; cells/min,
mean±SE; 22.42±3.31) and adhering (Fig. 4B; cells/100μm; 7.33±
0.83) cells when compared to control mice (rolling: 0.83±0.29;
adhering: 0.89±0.32). PAFR−/− mice also presented high levels
(p<0.001) of rolling (15.54±2.49) and adhering (7.44±0.71)
leukocytes, similar to their WT counterparts but higher than
PAFR−/− controls (rolling: 0.67±0.14; adhering: 0.73±0.12) (Fig. 4).
2.4. Inflammatory cytokines are not elevated in
EAE-induced PAFR−/− mice
Wemeasured cytokines and chemokines known to be involved
in EAE. Cytokine IL-17 (pg/100 mg of tissue; mean±SE; 175.60±
Fig. 3 – NAG activity in brain stem tissue from controls and
EAE-induced mice. PAFR−/− EAE-induced mice (n=7)
presented significantly lower NAG levels when compared to
WTEAE-inducedmice (n=5). Results are expressed asmean±
SEM, where *p<0.05 and ***p<0.001.
Fig. 4 – Visualization of leukocyte–endothelium interaction in
the peak of EAE. Intravital microscopy was used to assess the
rolling and adhesion of leukocytes in brain microvasculature.
The protocol included control group (controls, WT=4,
PAFR−/−=4), WT EAE (n=4) and PAFR−/− EAE (n=9) mice on day
14 post immunization. Data indicate a mean±SEM of cells per
minutes (A) or cell/100 μm (B). Statistically significant
differences were indicated by ***p<0.001.
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39.61) were elevated in EAE-induced WT mice after 14 days of
immunization when compared to controls (IL-17: 117.40±9.50;
CCL2: 43.45±4.37; CCL5: 479.40±36.02; p<0.05) (Fig. 5) and
PAFR−/−mice after 14 days of EAE induction (IL-17: 146.50±5.08;
CCL2: 49.99±1.65; CCL5: 590.70±17.66; p<0.05). Also, there was
no difference between EAE-induced PAFR−/− mice and PAFR−/−
controls (IL-17: 157.00±16.40; CCL2: 54.85±3.79; CCL5: 632.90±
46.72).
2.5. CD4+ and IL-17-secreting cells are reduced in the brain
of EAE-induced PAFR−/− mice
Weperformed leukocytes isolation and staining to definewhich
cells were infiltrating the CNS (Fig. 6). EAE-induced WT mice
presented elevated levels of CD4+ stained cells (percentage of
CD4+staining; median<range>: 1.71<0.41–10.99>) when com-
pared to PAFR−/− (0.20<0.12–0.28>) mice after 14 days of
induction (p<0.01). There was also a higher staining of cells
synthesizing IL-17 (3.94<2.74–12.33>) in WT mice when com-
pared to PAFR−/− animals (2.75<2.21–3.29>; p<0.05).3. Discussion
In this work, we showed that the absence of PAF receptor
attenuates EAE. This better clinical outcome was associated
with lower levels of cytokines and reduced mononuclear cell
infiltration in the CNS. Interestingly, there was a change in the
profile of the inflammatory infiltrate composed mainly of
neutrophils and eosinophils, while no alteration in pivotal
steps (rolling and adhesion) of cell recruitment was noticed.
Also, of great importance, T-helper (Th)17 response seems to
be impaired in EAE-induced PAFR−/− mice.
Induction of EAE results in hind limbs paresis and paralysis
in WT mice following resolution of disease by recovery of
clinical signs. Milder disease in animals lacking the PAFreceptor confirmed previous studies investigating PAF in EAE.
Kihara et al. (2005) reported diminished disease incidence in
PAFR−/− mice and a better recovery of clinical signs. Clinical
signs in EAE are elicited due to loss ofmyelin and axons in CNS
tissue (Wujek, et al., 2002). Mononuclear cells infiltrating the
CNS are thought to be the effectors ofmyelin and axon damage
(Zeine and Owens, 1992). EAE-induced PAFR−/−mice presented
fewer mononuclear cells in spinal cords and reduced macro-
phage sequestration in brainstem when compared to WT
animals, suggesting that absence of PAF receptor is impairing
recruitment of these cells to CNS.
One possibility that could explain lower mononuclear cell
infiltration could be diminished rolling and adhesion of these
cells in CNS microvasculature. To evaluate rolling and
adhesion steps of leukocyte recruitment, we performed
intravital microscopy in cerebral microvasculature at the
peak of EAE in WT animals. EAE-induced WT animals present
increased levels of rolling and adhered leukocytes, as already
Fig. 5 – Kinetics of chemokine protein production in the CNS of
EAE mice. Protein concentrations were measured in brain
extracts byELISAonday 14 after immunizationwithMOG35–55.
Assay was performed in EAE mice (WT=6; PAFR−/−=7) and
control group (WT=4, PAFR−/−=5) for IL-17 (A), CCL2 (B) and
CCL5 (C). Results were expressed as the mean±SEM.
Statistically significant differences were indicated by *p<0.05
and ***p<0.001.
302 B R A I N R E S E A R C H 1 3 8 5 ( 2 0 1 1 ) 2 9 8 – 3 0 6assessed by previous work from our group (dos Santos et al.,
2005; Rodrigues et al., 2010; Teixeira et al., 2010). Surprisingly,
PAFR−/− mice presented similar levels of leukocyte rolling andadhesion when compared to WT mice. Rolling and adhesion
are steps of recruitment which depend on the expression of
selectins and adhesion molecules and are influenced by the
presence of chemokines in tissue (Schenkel et al., 2004).
Nonetheless, migration and survival of migrating cells in
tissue parenchyma depend on many other molecules. Thus,
it is possible that the PAF receptor may not be relevant for the
expression of molecules responsible for rolling and adhesion.
In this line, our results also suggest that although rolling and
adhesion of leukocytes are crucial steps of cell recruitment,
they are not sufficient to promote cell infiltration through the
blood–brain barrier. Conversely, the high levels of neutrophils
and eosinophils in CNS from PAFR−/− mice could indicate that
rolling and adhering leukocytes in these animals are neutro-
phils and eosinophils, whereas the majority of rolling and
adhering cells in WT mice are from mononuclear lineage.
Unfortunately, rhodamine stains all kinds of leukocytes,
therefore it is not possible to state whether rolling and
adhering leukocytes are mononuclear or polymorphonuclear
cells.
The presence of neutrophils and eosinophils in CNS tissue
from PAFR−/− mice reveals a bias towards recruitment of
polymorphonuclear leukocytes in these mice. Interestingly,
Wu et al. (2010) found a high number of neutrophils during
onset andpeakof EAE, suggesting that neutrophils contribute to
theaggravationof disease. Furthermore, Kang et al. (2010) found
that CD4+ T cells recruited by astrocytes are essential for EAE
onset. Therefore, we hypothesize that neutrophils in CNS from
PAFR−/− mice may need signals provided by mononuclear cells
(CD4+T cells) to promote tissue damage. Further studies are
needed to define which signals may be influencing neutrophil-
mediated tissue damage.
Infiltrating cells synthesize molecules to recruit and
activate more cells to invade CNS tissue (Reboldi et al., 2009).
It has been established that EAE-induced mice present
elevated cytokines and chemokines levels in CNS tissue at
the peak of EAE (Fife et al., 2001; Juedes et al., 2000; Ambrosini
et al., 2003). We confirmed the presence of high levels of
proinflammatory cytokines and chemokines in EAE-induced
WT mice. However, PAFR−/− mice presented levels compared
to control mice in all cytokines and chemokines measured,
suggesting that infiltrating cells in these mice were not
synthesizing these molecules. Lack of PAF receptor may be
impairing IL-17 release by astrocytes, which were shown to be
the source of this cytokine in the onset of EAE clinical signs
(Kang et al., 2010). In addition, lack of mononuclear cells in
CNS tissue, which was shown by the diminished number of
CD4+ lymphocytes, may result in lower cytokine and chemo-
kine synthesis. Kihara et al. (2005) found a decreased
phagocytic activity in PAFR−/−macrophages. Our data suggest
that the reduced amount of IL-17 and diminished number of
CD4+ cells may account for the reduced phagocytic activity of
macrophages lacking PAFR.
Th17 response has been shown to be relevant in EAE
(Langrish et al., 2005). To our knowledge, we showed, for the
first time, that this response may be impaired in EAE-
induced PAFR−/− mice. The need for Th17 responses to induce
EAE is still a matter of debate. While some studies consider it
to be essential (Kroenke and Segal, 2007), others claim that it
is not necessary (Kroenke, et al., 2010). We show here an
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response.4. Conclusions
In conclusion, we have shown that PAF receptor is important
in the induction and development of EAE. Absence of this
receptor leads to milder mononuclear cell infiltration, de-
crease of CD4+ Th17 lymphocytes and lower levels of
inflammatory cytokines and chemokines in CNS tissue, but
no influence on leukocyte rolling and adhesion.5. Experimental procedures
5.1. Mice
Female C57BL/6 mice were obtained from Animal Care
Facilities of Federal University of Minas Gerais (UFMG, Brazil),
aged between 9 and 10 weeks. Female PAFR−/− mice with the
same age of C57BL/6 were a kind gift from professor Takao
Shimizu (University of Tokyo) and were bred and maintained
under SPF conditions at Instituto de Ciências Biológicas. The
Animal Ethics Committee of UFMG approved all experimental
procedures used (protocol number: 129/2006).
5.2. EAE induction and clinical assessment
EAE was induced using an emulsion containing myelin oligo-
dendrocyte glycoprotein (MOG), Complete Freund's Adjuvant
(CFA) and attenuated Mycobacterium tuberculosis. Pertussis toxin
was injected separately and intraperitoneally. MOG peptide,
sequence 35–55 (MEVGWYRSPFSRVVHLYRNGK; Auspep) was
obtained from NeoMPS (San Diego, USA). Pertussis toxin and
CFA were purchased from Sigma Chemical Co (St. Louis, MO,
USA). Attenuated M. tuberculosis H37 RA was purchased from
Difco Laboratories (Sparks, MD, USA). Each animal received
100 μL of the emulsion in the base of tail containing 100 μg of
MOG35–55. Each animal received two i.p. doses of 300 ng of
pertussis toxin in the day of the immunization and 48 h later.
Animals were monitored daily and clinical score was
evaluated using a standard scoring system. Briefly, the score is
characterized as follows: 0=no signs; 0.5=tail weakness; 1=tail
paralysis; 2=hind limb weakness; 3=hind limb paralysis;
4=hind limb paralysis and front limb weakness. Animals were
also weighed daily.
5.3. Histopathology
Spinal cords were quickly removed after intravital microscopy
and preserved in 10% buffered formalin. The sections (4 μm)
were stained with hematoxylin and eosin (H&E) and analyzed
for CNS inflammation in an Olympus BX51 microscope.
5.4. Measurement ofN-acetyl-β-D-glucosaminidase activity
The extent of macrophage sequestration was quantified
indirectly by the measuring of N-acetyl-β-D-glucosaminidase(NAG) activity in brain supernatants, as an index of monocyte
influx (Lacerda-Queiroz et al., 2010). In brief, the brains of
control and immunized animals (on day 14 post immuniza-
tion) were removed, weighed and the tissue was homogenized
in extraction solution (100 mg of tissue per mL), containing
0.4M NaCl, 0.05% Tween 20, 0.5% BSA, 0.1 mM phenyl methyl
sulphonyl fluoride, 0.1 mM benzethonium chloride, 10 mM
EDTA and 20 KIU aprotinin, using Ultra-Turrax. Brain homog-
enate was centrifuged at 3000×g for 10 min at 4 °C and the
resultant pellet was resuspended in saline/Triton 0.1%. The
NAG reaction was run at 37 °C for 10 min in a 96-well
microplate following the addition of 100 μL p-nitrophenyl-N-
acetyl-β-D-glucosaminide (Sigma-Aldrich, St. Louis, MO), dis-
solved in citrate/phosphate buffer (0.1 M citric acid, 0.1 M
Na2HPO4, pH 4.5) at a final concentration of 2.24 mM. The
reaction was terminated by the addition of 100 μL 0.2M glycine
buffer (pH 10.6). NAG activity was assayed by measuring the
change in absorbance (optical density [OD]) at 405nm in a
spectrophotometer (Emax, Molecular Devices) and interpolat-
ed on a standard curve constructed with p-nitrophenol (0–
500 nmol/ml) (Sigma-Aldrich). Results were expressed as
change in O.D. per gram of tissue.
5.5. Intravital microscopy in mouse brain
Intravital microscopy of the mouse cerebromicrovasculature
was performed at day 14 post immunization as previously
described (Vilela et al., 2008). Briefly, mice were anesthetized
by intraperitoneal injection of a mixture of 150 mg/kg keta-
mine and 10 mg/kg Xylazine and the tail vein was cannulated
for administration of fluorescent dyes. A craniotomy was
performed using a high-speed drill (Dremel, USA) and the dura
mater was removed to expose the underlying pial vasculature.
Throughout the experiment, the mouse was maintained at
37 °C with a heating pad (Fine Science Tools Inc., Canada) and
the exposed brain was kept moist with an artificial cerebro-
spinal fluid buffer, an ionic composition in mmol/L: NaCl 132,
KCL 2.95, CaCL2 1.71, MgCL2 0.64, NaHCO3 24.6, dextrose 3.71
and urea 6.7, pH 7.4, at 37 °C. To observe leukocyte/endothe-
lium interactions, leukocytes were fluorescently labeled by
intravenous administration of rhodamine 6G (0.5 mg/kg body
weight) and observed using a microscope (Olympus B201, ×20
objective lens, corresponding a 100 μmof area) outfittedwith a
fluorescent light source (epi-illumination at 510–560 nm,
using a 590 nm emission filter). A silicon-intensified camera
(Optronics Engineering DEI-470) mounted on the microscope
projected the image onto a monitor (Olympus). Rolling
leukocytes were defined as white cells moving at a velocity
less than that of erythrocytes cells. Leukocytes were consid-
ered adherent to the venular endothelium if they remained
stationary for 30 s or longer.
5.6. Quantification ofMCP-1/CCL2, RANTES/CCL5 and IL-17
in CNS
Brain tissue extracts were obtained from control and exper-
imental mice that were sacrificed at 14 days after immuniza-
tion. Brains were removed after intravital microscopy, and left
and right hemispheres were stored on ice. Thereafter, frozen
hemispheres were homogenized in extraction solution
Fig. 6 – Flow cytometry analysis. Cells were obtained frombrain tissue of animals (WT EAE=8; PAFR−/− EAE=4) after 14 days of EAE
induction. Gates for lymphocytes, CD4+ and IL-17 producing cells are shown (A). CD4+ cells were increased inWT EAEmice when
compared to PAFR−/− EAE (B). Cells synthesizing IL-17 were also increased in WT EAEmice when compared to PAFR−/− EAE (C).
Results were expressed as the mean±SEM. Statistically significant differences were indicated by *p<0.05 and **p<0.01.
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Tween 20, 0.5% BSA, 0.1 mMPhenylmethyl sulphonyl fluoride,
0.1 mM benzethonium chloride, 10 mM EDTA and 20 KIU
aprotinin, using Ultra-Turrax. Brain homogenate was spun at
12,500×g for 10 min at 4 °C and supernatants were collected
and stored at −70 °C. The concentration of MCP-1/CCL2
(Monocyte Chemotactic Protein 1/Chemokine C–C motif
Ligand 2), RANTES/CCL5 (Regulated upon Activation, Normal
T-cell Expressed, and Secreted/Chemokine C–Cmotif Ligand 5)
and IL-17 was determined using ELISA.
5.7. CNS-infiltrating leukocyte isolation and staining
After sacrifice, brain was removed from mice and leucocytes
were then isolated from the brain by homogenization
through a nitex screen into RPMI (Roswell Park Memorial
Institute) media. This cell suspension was fractionated using
a step gradient consisting of 30% percoll (Sigma, St. Louis,
MO) diluted in RPMI layered over 75% percoll diluted in RPMI.
After centrifugation (8000×g), myelin was aspirated off thetop of the 30% percol layer. Leucocytes were removed from
the interface between the 75% and 30% layers of percoll.
Afterwards, leucocytes were centrifuged (600×g) and resus-
pended in 1 mL of a solution containing 0.5% Bovine Serum
Albumin (BSA), 2 mM azide and phosphate-buffered saline
(pH 7.4). Leukocytes obtained from CNS tissue were stained
with a combination of fluoresceine isothiocyanate (FITC) and
phycoerythrin (PE) labeled antibodies directed against sur-
face molecule CD4 and intracellular molecule IL-17, respec-
tively. Data were acquired using a FACScan (Becton
Dickinson, San José, CA, USA) and raw data of FACS analysis
were processed using the Cell Quest software (Becton
Dickinson, San José, CA, USA). Collected flow cytometry
data were analyzed using FlowJo software (Tree Star, Ash-
land, Oregon, USA) (Fig. 6).
5.8. Statistical analysis
Data are shown as mean±SEM. ANOVA parametric test with
Bonferroni correction was used for multiple comparisons. For
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tistical significance was set at p<0.05.Competing interests
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